Forest Labs Puts Up $1.5B For Furiex Pharmaceuticals
New York-based Forest Laboratories Inc. said Monday it will snap up gastrointestinal drug specialist Furiex Pharmaceuticals Inc. in a deal worth up to $1.46 billion, broadening its portfolio of pharmaceuticals in...To view the full article, register now.
Already a subscriber? Click here to view full article